Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement

Item

http://www.wikidata.org/entity/Q36633259

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Double-blind, placebo-controll ...... ificant short term improvement

@ast

Double-blind, placebo-controll ...... ificant short term improvement

@en

type

Item

label

Double-blind, placebo-controll ...... ificant short term improvement

@ast

Double-blind, placebo-controll ...... ificant short term improvement

@en

prefLabel

Double-blind, placebo-controll ...... ificant short term improvement

@ast

Double-blind, placebo-controll ...... ificant short term improvement

@en

P1476

Double-blind, placebo-controll ...... ificant short term improvement

@en

P2093

Angelika Thon

http://www.w3.org/2001/XMLSchema#string

Gerd Ganser

http://www.w3.org/2001/XMLSchema#string

Gerd Horneff

http://www.w3.org/2001/XMLSchema#string

Hans-Iko Huppertz

http://www.w3.org/2001/XMLSchema#string

Ivan Foeldvari

http://www.w3.org/2001/XMLSchema#string

Jasmin Kuemmerle-Deschner

http://www.w3.org/2001/XMLSchema#string

Kirsten Minden

http://www.w3.org/2001/XMLSchema#string

Michael Borte

http://www.w3.org/2001/XMLSchema#string

Nicolay Tzaribacev

http://www.w3.org/2001/XMLSchema#string

Rolf Trauzeddel

http://www.w3.org/2001/XMLSchema#string

P2860

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.

TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides.

P2888

ar4072

P304

R230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR4072

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jasmin Kümmerle-Deschner

P577

2012-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232698740

http://www.w3.org/2001/XMLSchema#string

P6179

1022468040

http://www.w3.org/2001/XMLSchema#string

P698

23095307

http://www.w3.org/2001/XMLSchema#string

P921

placebo

adalimumab

P932

3580542

http://www.w3.org/2001/XMLSchema#string